PD-1 mRNA expression in peripheral blood cells and its modulation characteristics in cancer patients

Immune checkpoint inhibitors that block the PD-1/PD-L1 signaling pathway have been used to treat a wide variety of cancers. Although results have been promising, significant inter-individual and inter-tumor variability has been observed. It is believed that better clinical outcome could be achieved...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Wang, Wei, Shen, Ge, Wu, Shikai, Song, Shiping, Ni, Yanli, Suo, Zhuoyao, Meng, Xiangying, Li, Dan, Zhou, Lin, Hao, Rimin, Zhao, Yaowei, Bai, Li, Hou, Lili, Liu, Bing, Liu, Guangxian
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584204/
https://ncbi.nlm.nih.gov/pubmed/28881603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados